VICE PRESIDENT, OPERATIONS AND DEVELOPMENTIdentify and evaluate new business opportunitiesContribute to overall business strategyEvaluate and manage CROs and consultants for research, cGMP fill finish, Quality and IND enabling preclinical studiesDIRECTOR OF BUSINESS DEVELOPMENT AND INTELLECTUAL PROPERTY (2015 - 2017)Opportunity identification and assessmentManage contracts, IP, and relationships with university partnersIn-license technologies as the basis for drug development projectsProject management for research projects, establishing a Quality Management system, and IND enabling studies

Commercialized life sciences technologies invented by OHSU researchers Evaluated invention disclosures for commercial potential and patentabilityAligned patent prosecution with commercial and licensing strategyIdentified potential licensees and market technologiesNegotiated license dealsHelped form start up companiesDrafted agreements: NDA, MTA, License, Sponsored Research, and collaboration agreementsGive presentations, engage in inventor outreachResolved conflicts with existing agreements

Contributed to antibody engineering drug development efforts, co-inventing two approved drugs: Praxbind (idarucizumab) and Skyrizi (risankizumab).Identify new technologies that align with strategic drug development goals and evaluated research and licensing partnerships .Participated in due diligence review of potential deals.Contributed to Lean/six-sigma process improvement projects to accelerate intra-organization hand offs between R&D and preclinical development.

Assist clients with- strategic decision making- valuation scenarios- market opportunity identification- licensing / acquisition / and divestiture evaluation

Intellectual property managementOut-licensingNegotiationStart-up company formation

- R&D, antibody development/engineering-assay development high-throughput screening